Loxo Oncology Inc (NASDAQ:LOXO)

104.80
Delayed Data
As of Feb 16
 -0.17 / -0.16%
Today’s Change
40.02
Today|||52-Week Range
108.50
+24.50%
Year-to-Date

Today’s Trading

Previous close104.97
Today’s open104.70
Day’s range103.77 - 105.78
Volume155,351
Average volume (3 months)411,953
Market cap$3.1B
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)-63.21%
Earnings growth (this year)-68.58%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book17.46

Competitors

 Today’s
change
Today’s
% change
RAREUltragenyx Pharmaceu...-0.40-0.84%
SRPTSarepta Therapeutics...+0.86+1.36%
IRWDIronwood Pharmaceuti...-0.14-0.90%
PRTAProthena Corporation...+1.09+3.39%
Data as of 4:00pm ET, 02/16/2018

Financials

Next reporting dateMarch 30, 2018
EPS forecast (this quarter)-$1.25
Annual revenue (last year)$0.00
Annual profit (last year)-$72.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Josh Bilenker
Executive Director-
Business Operations
Sara Slifka
Corporate headquarters
Stamford, Connecticut

Forecasts